What is Malarone
Approved as Treatment by the FDA
Atovaquone, otherwise called Mepron, is approved by the FDA for 2 uses which include Malaria and Malaria .Effectiveness
When to interrupt dosage
The recommended dosage of Malarone is contingent upon the diagnosed condition, such as prophylaxis of Pneumocystis jiroveci pneumonia, Genus Pneumocystis and Toxoplasmosis. The amount of dosage can be found in the table below, contingent upon the method of administration, including Tablet - Oral or Tablet, film coated - Oral.Warnings
There are 20 known major drug interactions with Malarone.Malarone Novel Uses: Which Conditions Have a Clinical Trial Featuring Malarone?
Currently, 124 active clinical trials are evaluating the potential of Malarone in providing relief to those suffering from Malaria, Babesiosis and HIV.Malarone Reviews: What are patients saying about Malarone?
Patient Q&A Section about malarone
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What does Malarone do to your body?
"Malarone helps to prevent the growth of parasites in human red blood cells. These parasites usually enter the body through a mosquito bite and can cause malaria. Malaria is common in areas of Africa, South America, and Southern Asia. Malarone can be used to help treat or prevent malaria."
Who should not take Malarone?
"You should take atovaquone- proguanil with food.
If you are pregnant, have an infant that weighs less than 5kg, are nursing, have severe kidney disease, or are taking medications that affect your liver or kidney function, you should not take atovaquone-proguanil. You should take atovaquone-proguanil with food."
How long is it safe to take Malarone for?
"The course should be started 1 or 2 days before entering a country with a risk of malaria and taken daily for the entire duration of your stay. The course should then be continued for 7 days after leaving the affected area."